SUMMARY Total glycosylated haemoglobin (HbA1) levels from capillary blood were studied retrospectively during a 1-year period in 148 diabetic children aged between 1 9 and 16 8 years. The clinic range for HbA1 was 6-7 to 22 2 % and the results were normally distributed (mean ± SD 13 2 ± 2-8 %). The normal range in non-diabetics using this method is 4 9 to 8-0 %. Results from children who had had diabetes for more than 5 years were higher than those from children with diabetes of 2 to 5 years' duration. Girls had higher average values during the 1-year period than boys. HbA1 measurement serves to identify the deficiencies of current diabetic treatment regimens. It also has more immediate practical benefits in focusing attention on children whose control is deteriorating.
Interest in diabetic management has intensified lately as evidence has increased that good glucose control can reduce microvascular complications.1-3 In the past accurate assessment of control has not been possible. It is not sufficient to rely solely on clinical well-being and normal growth; random tests of blood sugar in the diabetic clinic are of little help because the normal day-to-day routine will have been interupted, and the time at which such tests are taken will vary. Urine tests remain the cornerstone of control, but there are obvious pitfalls promoting inappropriate insulin adjustments.
Glycosylation of HbA appears to be a slow, nonenzymatic process taking place during the life of the red cell. Glycosylated haemoglobin (HbA1) levels reflect the integrated blood glucose level during the preceding 2 months.45 They are an objective measurement being independent of patient cooperation, time of day, insulin administration, or meals, and their role in the management of the diabetic patient has recently been reviewed. HbAj over the year of all patients out of remnission (13.2 ± 21 %). The HbA1 levels in remission were significantly lower than the rest (P<0.01) ( Table 2) . A sex difference was present between HbA1 levels of boys (12.8 ± 2-3%) and girls (13-6 ± 1.9%) compared with the patients' average HbA1 throughout the year (P<0*05). Table 3 shows that this sex difference is present only in children older than 12 years. There was a weak correlation between HbA1 levels and clinic blood glucose (correlation coefficient 0.23). High (20-25 mmol/l) clinic blood glucose levels were more common in children with high 
